Targeting N-acetylglucosamine-bearing polymer-coated liposomes to vascular smooth muscle cells

Journal of Artificial Organs

Volumn 14, Issue 4, 2011, Pages 301-309

  Ise, Mamiko ^a   Ise, Hirohiko ^b   Shiba, Yuji ^a   Kobayashi, Satoshi ^a   Goto, Mitsuaki ^c   Takahashi, Masafumi ^d   Akaike, Toshihiro ^b   Ikeda, Uichi ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c Celagix Res Ltd   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Drug delivery system; Lectin; N acetylglucosamine; Restenosis; Vascular smooth muscle cells

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN DECOY OLIGONUCLEOTIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOSOME; N ACETYLGLUCOSAMINE; OLIGONUCLEOTIDE; POLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; CELL SUSPENSION; CELL VIABILITY; DRUG ACTIVATION; DRUG DELIVERY SYSTEM; DRUG UPTAKE; FEMORAL ARTERY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HEART MUSCLE CELL; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER; UMBILICAL VEIN ENDOTHELIAL CELL;

ACETYLGLUCOSAMINE; ANGIOPLASTY; ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-6; LIPOSOMES; MUSCLE CELLS; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR SYSTEM INJURIES; VIMENTIN;

EID: 84855254621     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-011-0595-3     Document Type: Article

References (21)

1. Babapulle MN, Eisenberg MJ. Coated stents for the prevention of restenosis: part I. Circulation. 2002;106:2734-40. (Pubitemid 35364930)
2. Carter AJ, Aggarwal M, Kopia GA, Tio F, Tsao PS, Kolata R, Yeung AC, Llanos G, Dooley J, Falotico R. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res. 2004;63:617-24. (Pubitemid 39078675)
3. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus- eluting stent: should we be cautious? Circulation. 2004;109:701-5. (Pubitemid 38222887)
4. Yamazaki N, Kojima S, Bovin NV, Andre S, Gabius S, Gabius HJ. Endogenous lectins as targets for drug delivery. Adv Drug Deliv Rev. 2000;43:225-44.
5. Nishikawa M. Development of cell-specific targeting system for drugs and genes. Biol Pharm Bull. 2005;28:195-200. (Pubitemid 40879993)
6. Weis WI, Drickamer K. Structural basis of lectin-carbohydrate recognition. Annu Rev Biochem. 1996;65:441-73. (Pubitemid 26250616)
7. Cook SE, Park IK, Kim EM, Jeong HJ, Park TG, Choi YJ, Akaike T, Cho CS. Galactosylated polyethylenimine-graft-poly(vinylpyrrolidone) as a hepatocyte-targeting gene carrier. J Control Release. 2005;105:151-63. (Pubitemid 40805483)
8. Ise H, Kobayashi S, Goto M, Sato T, Kawakubo M, Takahashi M, Ikeda U, Akaike T. Vimentin and desmin possess GlcNAcbinding lectin-like properties on cell surfaces. Glycobiology. 2010;20:843-64.
9. Aso S, Ise H, Takahashi M, Kobayashi S, Morimoto H, Izawa A, Goto M, Ikeda U. Effective uptake of N-acetylglucosamineconjugated liposomes by cardiomyocytes in vitro. J Control Release. 2007;122:189-98. (Pubitemid 47364749)
10. Kobayashi S, Ise H, Takahashi M, Goto M, Akaike T, Ikeda U. Surface coating of bone marrow cells with N-acetylglucosamine for bone marrow implantation therapy. Biomaterials. 2009;30:574-82.
11. Kim SJ, Ise H, Goto M, Komura K, Cho CS, Akaike T. Gene delivery system based on highly specific recognition of surfacevimentin with N-acetylglucosamine immobilized polyethylenimine. Biomaterials. 2011;32:3471-80.
12. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715-22. (Pubitemid 26105480)
13. Yamasaki K, Asai T, Shimizu M, Aoki M, Hashiya N, Sakonjo H, Makino H, Kaneda Y, Ogihara T, Morishita R. Inhibition of NFkappaB activation using cis-element 'decoy' of NF-kappaB binding site reduces neointimal formation in porcine ballooninjured coronary artery model. Gene Ther. 2003;10:356-64. (Pubitemid 36312932)
14. Ikeda U, Shimpo M, Ikeda M, Minota S, Shimada K. Lipophilic statins augment inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. J Cardiovasc Pharmacol. 2001;38:69-77. (Pubitemid 32634991)
15. Ogata Y, Takahashi M, Takeuchi K, Ueno S, Mano H, Ookawara S, Kobayashi E, Ikeda U, Shimada K. Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy. J Cardiovasc Pharmacol. 2002;40:907-15. (Pubitemid 35365089)
16. Sata M, Maejima Y, Adachi F, Fukino K, Saiura A, Sugiura S, Aoyagi T, Imai Y, Kurihara H, Kimura K, Omata M, Makuuchi M, Hirata Y, Nagai R. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol. 2000;32:2097-104.
17. Yoshioka T, Takahashi M, Shiba Y, Suzuki C, Morimoto H, Izawa A, Ise H, Ikeda U. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res. 2006;70:61-9.
18. Shiba Y, Takahashi M, Hata T, Murayama H, Morimoto H, Ise H, Nagasawa T, Ikeda U. Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis. Cardiovasc Res. 2009;81:169-77.
19. Morimoto H, Takahashi M, Shiba Y, Izawa A, Ise H, Hongo M, Hatake K, Motoyoshi K, Ikeda U. Bone marrow-derived CXCR4? cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice. Am J Pathol. 2007;171:755-66. (Pubitemid 47440975)
20. Ogawa T, Kawada N, Ikeda K. Effect of natural interferon alpha on proliferation and apoptosis of hepatic stellate cells. Hepatol Int. 2009;3:497-503.
21. Ivaska J, Pallari HM, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res. 2007;313:2050-62. (Pubitemid 46842979)